Global Burden Attributable to High Low-Density Lipoprotein-Cholesterol From 1990 to 2019
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Global Burden Attributable to High Low-Density Lipoprotein-Cholesterol From 1990 to 2019
Authors
Keywords
-
Journal
Frontiers in Cardiovascular Medicine
Volume 9, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2022-06-09
DOI
10.3389/fcvm.2022.903126
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Safety of proprotein convertase subtilisin/kexin 9 inhibitors: a systematic review and meta-analysis
- (2022) Jing Li et al. HEART
- PCSK9 inhibitors and ezetimibe with or without statin therapy for cardiovascular risk reduction: a systematic review and network meta-analysis
- (2022) Safi U Khan et al. BMJ-British Medical Journal
- PCSK9 inhibitors and ezetimibe for the reduction of cardiovascular events: a clinical practice guideline with risk-stratified recommendations
- (2022) Qiukui Hao et al. BMJ-British Medical Journal
- Different Lipid Parameters in Predicting Clinical Outcomes in Chinese Statin-Naïve Patients After Coronary Stent Implantation
- (2021) Li Zeng et al. Frontiers in Cardiovascular Medicine
- Heart Disease and Stroke Statistics—2020 Update: A Report From the American Heart Association
- (2020) Salim S. Virani et al. CIRCULATION
- The Expected 30-year Benefits of Early Versus Delayed Primary Prevention of Cardiovascular Disease by Lipid Lowering
- (2020) Michael Pencina et al. CIRCULATION
- Global burden of 87 risk factors in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019
- (2020) Christopher J L Murray et al. LANCET
- Global, regional, and national burden of neurological disorders, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016
- (2019) Valery L Feigin et al. LANCET NEUROLOGY
- Proprotein convertase subtilisin/kexin 9 inhibitors in reducing cardiovascular outcomes: a systematic review and meta-analysis
- (2019) Heyue Du et al. HEART
- Health and health care in Israel: an introduction
- (2017) A Mark Clarfield et al. LANCET
- How is Indonesia coping with its epidemic of chronic noncommunicable diseases? A systematic review with meta-analysis
- (2017) Julia Schröders et al. PLoS One
- Global Burden of Disease Study 2015 provides GPS for global health 2030
- (2016) K Srinath Reddy LANCET
- Guidelines for Accurate and Transparent Health Estimates Reporting: the GATHER statement
- (2016) Gretchen A Stevens et al. LANCET
- Hyperlipidemia as a Risk Factor for Cardiovascular Disease
- (2012) Robert H. Nelson PRIMARY CARE
- Prevention of non-communicable disease in a population in nutrition transition: Tehran Lipid and Glucose Study phase II
- (2012) Fereidoun Azizi et al. Trials
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started